NRXP · NASDAQ
NRX Pharmaceuticals (NRXP) Stock Price & Fundamentals
NRX Pharmaceuticals (NRXP) closed at $523.99 on Oct 9, 2026, down 1.33% from the previous close of $531.05.
Share price, past year
1Y +40.31%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $523.99 |
| Sep 30, 2026 | $536.93 |
| Aug 31, 2026 | $491.04 |
| Jul 31, 2026 | $487.74 |
| Jun 30, 2026 | $482.48 |
| May 29, 2026 | $467.67 |
| Apr 30, 2026 | $467.22 |
| Mar 31, 2026 | $424.43 |
| Feb 27, 2026 | $393.19 |
| Jan 30, 2026 | $393.64 |
| Dec 31, 2025 | $397.48 |
| Nov 28, 2025 | $387.75 |
| Oct 31, 2025 | $394.99 |
Key statistics
- Market cap
- $22.61B
- P/E (TTM)
- —
- EPS (TTM)
- —
- Revenue (TTM)
- $3.39M
- Net income (TTM)
- −$23.48M
- Shares outstanding
- 43.2M
- Dividend yield
- —
- 52-week range
- $373.45 – $536.93
NRX Pharmaceuticals's market cap is $22.61B, based on a share price of $523.99 and 43.2M shares outstanding as of Jun 30, 2026.
Financials
NRX Pharmaceuticals reported revenue of $1.23M for fiscal 2025.
NRX Pharmaceuticals reported a net loss of $28.62M in fiscal 2025.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $1.23M | — | −$28.62M | −2,336.5% | — | — |
| FY2024ended Dec 31, 2024 | $0.00 | — | −$25.13M | — | — | — |
| FY2023ended Dec 31, 2023 | $0.00 | — | −$30.15M | — | — | — |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q2 FY2026ended Jun 30, 2026 | $1.10M | −$16.52M | — |
| Q1 FY2026ended Mar 31, 2026 | $1.07M | −$1.43M | — |
| Q4 FY2025ended Dec 31, 2025 | $983.00K | $361.00K | — |
| Q3 FY2025ended Sep 30, 2025 | $242.00K | −$5.89M | — |
| Q2 FY2025ended Jun 30, 2025 | $0.00 | −$17.58M | — |
| Q1 FY2025ended Mar 31, 2025 | $0.00 | −$5.51M | — |
| Q3 FY2024ended Sep 30, 2024 | $0.00 | −$1.62M | — |
Company profile
- Name
- NRX Pharmaceuticals, Inc.
- Ticker
- NRXP
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Pharmaceutical Preparations
- Headquarters
- 1201 Orange Street, Suite 600, Wilmington, DE 19801
- Incorporated in
- DE
- Fiscal year ends
- December
- SEC CIK
- 0001719406
Recent SEC filings
- Oct 5, 2026
- Sep 16, 2026
- Sep 14, 2026
- Aug 17, 2026
- Aug 14, 2026
- Aug 7, 2026
- Jul 22, 2026
- Jun 4, 2026
Frequently asked questions
What is NRX Pharmaceuticals's stock price?
NRX Pharmaceuticals (NRXP) closed at $523.99 on Oct 9, 2026, down 1.33% from the previous close of $531.05.
What is NRX Pharmaceuticals's market cap?
NRX Pharmaceuticals's market cap is $22.61B, based on a share price of $523.99 and 43.2M shares outstanding as of Jun 30, 2026.
How much revenue does NRX Pharmaceuticals make?
NRX Pharmaceuticals reported revenue of $1.23M for fiscal 2025.
Does NRX Pharmaceuticals pay a dividend?
NRX Pharmaceuticals's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from NRX Pharmaceuticals, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures